Qiu Chao, Xu Hui
Department of Neurology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 310006 Hangzhou, Zhejiang, China.
Actas Esp Psiquiatr. 2024 Dec;52(6):759-768. doi: 10.62641/aep.v52i6.1762.
Liquid-liquid phase separation (LLPS) has been increasingly recognized as a crucial mechanism in the pathogenesis of various neurodegenerative disorders, including Alzheimer's disease (AD). There remains a paucity of effective diagnostic biomarkers for this condition. This study aims to develop and validate a novel LLPS-related molecular signature to enhance the diagnostic accuracy and early detection of AD.
LLPS-related genes were identified from online databases and subjected to bioinformatic analyses, including protein-protein interaction (PPI) network analysis and least absolute shrinkage and selection operator (LASSO) regression. Based on the optimal LLPS-related genes, a diagnosis risk model was constructed, and the diagnostic ability was evaluated using a receiver operator characteristic (ROC) curve. To elucidate the biological functions of the identified LLPS-related genes, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were conducted.
A total of 149 LLPS-related genes were screened, which were found to be involved in functions related to oxidative stress, apoptosis, and cancer progression. The 149 genes were refined to six optimal candidates through PPI network analysis and LASSO regression: Activator of HSP90 ATPase Activity 1 (AHSA1), Eukaryotic Translation Initiation Factor 2 Alpha Kinase 2 (EIF2AK2), Heat Shock Protein Family A (Hsp70) Member 4 (HSPA4), Notch Receptor 1 (NOTCH1), Superoxide Dismutase 1 (SOD1), and Thioredoxin (TXN). Based on the six optimal genes, a diagnostic risk model was constructed, and the diagnostic ability was verified to be promising in AD both in training, internal validation, and two external validation datasets, with area under ROC curve (AUC) above 0.8. Furthermore, significant correlations were observed between the expression of these genes and tumor immune cell infiltration.
A six-gene diagnosis model was constructed and verified to exhibit robust diagnostic ability in AD.
液-液相分离(LLPS)已越来越被认为是包括阿尔茨海默病(AD)在内的各种神经退行性疾病发病机制中的关键机制。目前针对这种疾病仍然缺乏有效的诊断生物标志物。本研究旨在开发并验证一种新型的与LLPS相关的分子特征,以提高AD的诊断准确性和早期检测率。
从在线数据库中鉴定出与LLPS相关的基因,并进行生物信息学分析,包括蛋白质-蛋白质相互作用(PPI)网络分析和最小绝对收缩和选择算子(LASSO)回归。基于最佳的与LLPS相关的基因,构建诊断风险模型,并使用受试者工作特征(ROC)曲线评估诊断能力。为了阐明所鉴定的与LLPS相关基因的生物学功能,进行了基因本体论(GO)和京都基因与基因组百科全书(KEGG)分析。
共筛选出149个与LLPS相关的基因,发现它们参与了与氧化应激、细胞凋亡和癌症进展相关的功能。通过PPI网络分析和LASSO回归,将这149个基因优化为六个最佳候选基因:热休克蛋白90 ATP酶活性激活因子1(AHSA1)、真核翻译起始因子2α激酶2(EIF2AK2)、热休克蛋白家族A(Hsp70)成员4(HSPA4)、Notch受体1(NOTCH1)、超氧化物歧化酶1(SOD1)和硫氧还蛋白(TXN)。基于这六个最佳基因,构建了诊断风险模型,并且在训练集、内部验证集和两个外部验证数据集中,该模型在AD诊断中的能力均得到验证,ROC曲线下面积(AUC)均高于0.8。此外,观察到这些基因的表达与肿瘤免疫细胞浸润之间存在显著相关性。
构建并验证了一个六基因诊断模型,该模型在AD中表现出强大的诊断能力。